Panzer S - Search Results

1

Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. Thromb Haemost. 2009 Feb;101(2):333-9. Thromb Haemost. 2009. PMID: 19190818 Clinical Trial.

2

The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity.

Gremmel T, Kopp CW, Seidinger D, Giurgea GA, Koppensteiner R, Steiner S, Panzer S. Gremmel T, et al. Among authors: panzer s. Atherosclerosis. 2009 Dec;207(2):608-13. doi: 10.1016/j.atherosclerosis.2009.05.037. Epub 2009 Jun 18. Atherosclerosis. 2009. PMID: 19616779

3

Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. Thromb Res. 2009 Nov;124(5):588-91. doi: 10.1016/j.thromres.2009.06.012. Epub 2009 Jul 23. Thromb Res. 2009. PMID: 19631365

4

Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. Heart. 2010 Feb;96(3):186-9. doi: 10.1136/hrt.2009.171488. Epub 2009 Aug 16. Heart. 2010. PMID: 19687016

5

Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?

Gremmel T, Calatzis A, Steiner S, Kaider A, Seidinger D, Koppensteiner R, Kopp CW, Panzer S. Gremmel T, et al. Among authors: panzer s. Platelets. 2010;21(7):515-21. doi: 10.3109/09537104.2010.493587. Platelets. 2010. PMID: 20624009 Free article.

6

The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. J Cardiovasc Pharmacol. 2010 Nov;56(5):532-9. doi: 10.1097/FJC.0b013e3181f68209. J Cardiovasc Pharmacol. 2010. PMID: 20729752

7

Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. Platelets. 2011;22(3):188-95. doi: 10.3109/09537104.2010.543963. Epub 2011 Jan 13. Platelets. 2011. PMID: 21231857 Free article.

8

The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients.

Gremmel T, Kopp CW, Steiner S, Seidinger D, Ay C, Koppensteiner R, Mannhalter C, Panzer S. Gremmel T, et al. Among authors: panzer s. Atherosclerosis. 2011 Jul;217(1):135-8. doi: 10.1016/j.atherosclerosis.2011.03.029. Epub 2011 Mar 31. Atherosclerosis. 2011. PMID: 21497813

9

A high maintenance dose increases the inhibitory response to clopidogrel in patients with high on-treatment residual platelet reactivity.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Gremmel T, et al. Among authors: panzer s. Int J Cardiol. 2012 Oct 4;160(2):109-13. doi: 10.1016/j.ijcard.2011.04.001. Epub 2011 May 4. Int J Cardiol. 2012. PMID: 21546102 Clinical Trial.

10

Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrel.

Gremmel T, Panzer S. Gremmel T, et al. Among authors: panzer s. Thromb Haemost. 2011 Aug;106(2):211-8. doi: 10.1160/TH11-03-0137. Epub 2011 May 26. Thromb Haemost. 2011. PMID: 21614418 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters